Richard Moxon1, Matthew D Snape2. Show Affiliations » 1. Department of Paediatrics, University of Oxford, Oxford OX3 7LE, UK. 2. Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Abstract
Mesh: See more » Cost-Benefit AnalysisDrug CostsHumansImmunization Programs/economicsMeningitis, Meningococcal/economicsMeningitis, Meningococcal/prevention & controlMeningococcal Vaccines/economicsNeisseria meningitidis, Serogroup BUnited KingdomVaccination/economics
Substances: See more » 4CMenB vaccineMeningococcal Vaccines
Year: 2013 PMID: 23911365 DOI: 10.1016/S0140-6736(13)61572-X
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321